Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06459271 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06459271 · ClinicalTrials.gov record · last posted 2026-08-24

Feasibility of CALM in Patients With Ovarian Cancer

StatusRecruiting
PhaseNot applicable
Started2024-06-10
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The goal of this feasibility trial is to determine the feasibility and acceptability of implementing a brief evidence-based psychotherapeutic intervention, Managing Cancer And Living Meaningfully (CALM), at the time of a new diagnosis and recurrence of ovarian cancer (OC). The main questions are: 1. Is it feasible and acceptable to implement CALM for patients with newly diagnosed or recently recurred advanced OC 2. What is the patient experience of CALM-TF at new diagnosis or recurrence Participants will be asked to complete questionnaires at baseline and at 3 and 6 months following a diagnosis or recurrence of stage III or IV OC. Participants will also be invited to participate in 3-6 sessions of CALM therapy.

Protocol amendment history 6 changes detected by DataLookout

2026-08-25
Enrollment reopened
2026-08-25
Primary completion pushed: 2026-12-06 → 2027-02
2026-08-25
Completion pushed: 2027-01 → 2027-06
2026-08-21
Enrollment closed, study ongoing
2026-08-21
Primary completion pushed: 2026-06-10 → 2026-12-06
2026-08-21
Completion pushed: 2026-08-10 → 2027-01
Trial Details
NCT Number NCT06459271
Lead Sponsor University Health Network, Toronto
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions Patient Satisfaction, Ovarian Cancer
Enrollment 50 participants
Start Date 2024-06-10
Primary Completion 2027-02 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-24